GACM
Global Alpha Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.3M | Buy |
862,090
+126,500
| +17% | +$8.25M | 3.51% | 8 |
|
|
2025
Q1 | $49.2M | Buy |
735,590
+111,040
| +18% | +$7.43M | 3.58% | 6 |
|
|
2024
Q4 | $34.5M | Buy |
624,550
+88,100
| +16% | +$4.87M | 2.51% | 16 |
|
|
2024
Q3 | $32M | Buy |
536,450
+9,500
| +2% | +$567K | 2.08% | 23 |
|
|
2024
Q2 | $33.6M | Buy |
526,950
+136,200
| +35% | +$8.67M | 2.45% | 16 |
|
|
2024
Q1 | $27M | Sell |
390,750
-191,678
| -33% | -$13.3M | 2.01% | 22 |
|
|
2023
Q4 | $32.1M | Buy |
582,428
+56,900
| +11% | +$3.14M | 2.58% | 14 |
|
|
2023
Q3 | $30.5M | Buy |
525,528
+72,200
| +16% | +$4.19M | 3.06% | 11 |
|
|
2023
Q2 | $24.4M | Sell |
453,328
-9,633
| -2% | -$519K | 2.29% | 22 |
|
|
2023
Q1 | $18.4M | Buy |
462,961
+13,430
| +3% | +$533K | 1.67% | 26 |
|
|
2022
Q4 | $18.1M | Buy |
449,531
+30,200
| +7% | +$1.21M | 1.77% | 25 |
|
|
2022
Q3 | $13.5M | Buy |
419,331
+95,600
| +30% | +$3.07M | 1.35% | 30 |
|
|
2022
Q2 | $9.61M | Sell |
323,731
-26,500
| -8% | -$786K | 1.04% | 32 |
|
|
2022
Q1 | $9.85M | Buy |
350,231
+65,400
| +23% | +$1.84M | 0.85% | 35 |
|
|
2021
Q4 | $13.1M | Buy |
284,831
+220,399
| +342% | +$10.2M | 1.27% | 31 |
|
|
2021
Q3 | $2.12M | Buy |
+64,432
| New | +$2.12M | 0.23% | 35 |
|
|
2020
Q4 | – | Sell |
-258,946
| Closed | -$7.31M | – | 37 |
|
|
2020
Q3 | $7.31M | Sell |
258,946
-16,300
| -6% | -$460K | 1.12% | 32 |
|
|
2020
Q2 | $8.9M | Buy |
275,246
+57,500
| +26% | +$1.86M | 1.41% | 29 |
|
|
2020
Q1 | $8.87M | Buy |
217,746
+48,000
| +28% | +$1.96M | 1.6% | 25 |
|
|
2019
Q4 | $10.5M | Buy |
169,746
+22,700
| +15% | +$1.4M | 1.55% | 27 |
|
|
2019
Q3 | $10.7M | Buy |
147,046
+4,600
| +3% | +$335K | 1.86% | 20 |
|
|
2019
Q2 | $11.7M | Buy |
142,446
+45,935
| +48% | +$3.78M | 2.04% | 21 |
|
|
2019
Q1 | $6.81M | Buy |
+96,511
| New | +$6.81M | 1.3% | 34 |
|